
Jemtaz 4.5 Injection
Marketer
Jemster Healthcare Private Limited
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Jemtaz 4.5 Injection
Combiflox 4.5 Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by healthcare providers, self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on infection severity, adhering precisely to the prescribed regimen is crucial. Commonly reported side effects encompass nausea, vomiting, diarrhea, and skin rashes; injection site reactions may include pain, swelling, or inflammation. Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, kidney, or liver conditions to your doctor, who may adjust the dosage or select an alternative medication. Under medical guidance, this injection is generally deemed safe for pregnant and breastfeeding individuals.
Uses of Jemtaz 4.5 Injection
Infections caused by bacteria
Major Benefits of Jemtaz 4.5 Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Jemtaz 4.5 Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Jemtaz 4.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Jemtaz 4.5 Injection works:
Jemtaz 4.5 Injection unites Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum counteracts bacterial resistance mechanisms, thereby bolstering Piperacillin's antimicrobial effect.
SAFETY ADVICE
AlcoholSAFE
There are no reported adverse reactions from concomitant use of Jemtaz 4.5 Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Jemtaz 4.5 is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; however, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The medication Jemtaz 4.5 Injection presents minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, posing no discernible threat to the infant.
DrivingCONSULT YOUR DOCTOR
Jemtaz 4.5 Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Exercise caution when administering Jemtaz 4.5 Injection to individuals with impaired renal function. Dosage modification for Jemtaz 4.5 Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Jemtaz 4.5 Injection in individuals with hepatic impairment appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Jemtaz 4.5 Injection :
Should you forget a scheduled Jemtaz 4.5 Injection, seek advice from your physician.
Facts to Know About Jemtaz 4.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
